Biogen (BIIB) Stock: Announces Buybacks After Painful Drop

Biogen BIIB Stock News

Biogen Inc (NASDAQ: BIIB) is making its way into the green this mroning after announcing a buyback program. The program comes after the company saw a painful drop in value after announcing the discontinuation of a clinical study. Today, we’ll talk about: The BIIB stock buyback program; what we’re seeing from the stock in the … Read more

Biogen (BIIB) Stock: Tumbling On Scrapped Phase 3 Development Program!

Biogen BIIB Stock News

Biogen Inc (NASDAQ: BIIB) is falling hard in the pre-market hours this morning, and for good reason. The company announced that it would be putting an end to a Phase 3 development program, upsetting investors and sending the stock tumbling down. Today, we’ll talk about: The scrapped development program; what we’re seeing from BIIB stock … Read more

Biogen (BIIB) Stock: Why It’s Falling After Positive Clinical Results

Biogen Inc (NASDAQ: BIIB) is falling hard early on in the pre-market this morning, and the declines may be confusing to some. That’s because the comapny released clinical results this morning that seemed to be overwhelmingly positive. With positive results in mind, stocks usually head up. So, what’s the deal here? Today, we’ll talk about: … Read more

Biogen (BIIB) Stock: Climbing On Earnings

Biogen Inc (NASDAQ: BIIB) is having an incredibly strong start to the trading session this morning, and for good reason. The company announced its earnings for the second quarter, beating expectations. The news also comes ahead of the company’s Alzheimer’s presentation. Of course, the strong earnings and coming catalysts are points of excitement for investors who … Read more

Ionis Pharmaceuticals (IONS) Stock: Expands Collaboration With Biogen (BIIB)

Ionis Pharmaceuticals Inc (NASDAQ: IONS) is headed for the top in the pre-market hours this morning after announcing an expanded collaboration with Biogen Inc (NASDAQ: BIIB). Of course, the news that the collaboration between the two companies is expanding is exciting to investors who are pushing the stock upward. Today, we’ll talk about: The expanded collaboration; … Read more

Biogen (BIIB) Stock: Gains On Positive Real-World Treatment Data

Biogen Inc (NASDAQ: BIIB) is having an incredibly strong time in the pre-market hours this morning, and for good reason. The company released data showing positive real-world experiences among patients using its leading MS therapies. As a result, investor excitement ensued and the stock found its way upward. As is almost always the case, our partners … Read more